Bear River Mental Health Prescribes with DoseSpot

Follow

About Bear River Mental Health:

Bear River Mental Health (BRMH) provides comprehensive mental health services to more than 3,000 patients annually at their eight locations across Utah.  Delivering mental health services according to the best practice guidelines with respect to appropriate medical necessity for more than 35 years, BRMH offers an array of services including:

• Assessments

• Behavior Management

• Crisis Management

• Medication Management

• Peer Support

• Psychological Testing

• Psychosocial Rehabilitation

• Psychotherapy

• Residential Services

• Respite Care

• Skills Development

e-Prescribing Integration:

“DoseSpot support is second to none” exclaims Thad Hunsaker, BRMH.  All eight of the BRMH offices use DoseSpot, with physicians accessing the e-Prescribing solution from multiple locations.  Thad explains, “Geographic location hasn’t added any difficulty where the service is provided online.” As a mental health organization, BRMH uses DoseSpot for more than just e-Prescribing.  “Patient medication management has long been an integral part of our treatment.  DoseSpot helps us manage this process online” adds Thad.  DoseSpot equips physicians with the capabilities to build a patient’s medication profile and then automatically review any drug-drug and drug-allergy interactions.

For the rest of this Case Study please visit http://www.dosespot.com/bear-river-mental-health.

One Touch EMR Prescribes with DoseSpot

Follow

Case Study:

One Touch EMR is designed to be simple and instinctive, allowing physicians to chart as fast as possible on their iPads and desktop computers. What makes their system unique is it was designed and developed by Dr. Robert Abbate, a physician who understands how physicians think and knows what is needed to provide an effective EMR solution that removes complexities rather than adding obstacles. Dr. Abbate designed One Touch EMR to replicate the medical school workflow students are trained in, making the solution more intuitive to physicians with the perks of being affordable and mobile. One Touch EMR is Stage 1 Meaningful Use certified and is used by more than 400 physicians across the United States.

e-Prescribing Integration:

During the planning and development stages of the One Touch EMR app, Dr. Abbate searched for an e-Prescribing platform that would seamlessly connect with his sleek and intuitive user interface. After thoroughly reviewing his options, Dr. Abbate selected DoseSpot because of its quick integration and easy to use user interface.

For the rest of this Case Study please visit www.DoseSpot.com/onetouchemr-case-study .

XLDent Prescribes with DoseSpot

Follow

Case Study:

XLDent™ began researching integration of an e-Prescribing solution when it was mandated in Minnesota. However, this was not the only reason they considered adding e-Prescribing.  XLDent™ had already developed a written prescription module within their software that could be fed to the Doctor Portal, but it did not contain the patient’s entire prescription history. The company was looking for a solution that could offer dentists a comprehensive view of a patient’s medication history from a mobile device, such as their smartphone when away from the office. Their interest was also to include a clinical decision support tool that would help clinicians improve patient outcomes.

Solution:

XLDentâ„¢ chose DoseSpot because of the ease of integration, its easy-to-use user interface, and the fact that it met all of their feature criteria. “The development team at DoseSpot was and continues to be great to work with!” said Dawn Christodoulou, President of XLDent. “They are very engaged and responsive to our needs.”

Telehealth Overview, Utilization and Trends

Follow

Gone are the days of taking the morning off from work to squeeze in a last minute doctor’s appointment to diagnose the flu-like symptoms you developed over night. The new alternative is telehealth, a concept that is bringing innovation to the traditional methods of healthcare delivery and accessibility, providing patients and doctors with greater flexibility and efficiency. Telehealth has already taken 2014 by storm and has instantly become the new healthcare IT buzz word. So much so that DoseSpot created a new Telehealth White Paper to share information on current telehealth utilization and upcoming trends. Within the white paper you will also find information on how telehealth companies can leverage e-Prescribing software to enhance the telehealth visit for both doctors and patients.

To download DoseSpot’s Telehealth White Paper, please visit www.dosespot.com/telehealth-whitepaper.

CMS Updates Meaningful Use Stages 2 and 3 Timeline

Follow

The Centers for Medicare & Medicaid Services (CMS) recently announced that Meaningful Use Stage 2 will be extended through 2016 and Stage 3 will be delayed until 2017.  In a joint blog post on CMS.gov, Robert Tagalicod (CMS) and Jacob Reider (Office of the National Coordinator for Health Information Technology, ONC) explain “the goal of this change is two-fold: first, to allow CMS and ONC to focus efforts on the successful implementation of the enhanced patient engagement, interoperability and health information exchange requirements in Stage 2; and second, to utilize data from Stage 2 participation to inform policy decisions for Stage 3.”

The post highlights a number of benefits to the new timeframe including:

• More analysis of feedback from stakeholders on Stage 2 progress and outcomes;

• More available data on Stage 2 adoption and measure calculations – especially on new patient engagement measures and health information exchange objectives;

• More consideration of potential Stage 3 requirements;

• Additional time for preparation for enhanced Stage 3 requirements;

• Ample time for developers to create and distribute certified EHR technology before Stage 3 begins, and incorporate lessons learned about usability and customization.

To read the announcement in full, visit www.cms.gov/eHealth/ListServ_Stage3Implementation.html.

Meaningful Consent

Follow

Healthcare providers have long advised patients on making informed care decisions.  Now, patients can rely on providers for guidance on how their electronic patient information is shared.   Yesterday, the U.S. Department of Health and Human Services (HSS) launched, Meaningful Consent, a new site for physicians to better help their patients navigate health information exchange (HIE).  Resources featured include customizable tools, law and policy information, videos and tutorials.

Key background information:

• HIE is the way healthcare providers share and access health information using technology
• HIEs share patient information between participating healthcare providers regarding a patient’s health information for treatment and payment
• Patient education and engagement is important to help them understand their options and outcomes of each option

Meaningful Consent is important to improve healthcare information technology and educate patients on HIE to foster greater trust in physician communication and health technologies. As the trend grows and HIEs evolve, it’s vital to have both physicians and patients engaged and informed to improve care and health outcomes.

Read the HSS press release here.

Health Disparities to be Tackled in Meaningful Use Stage 3

Follow

While EHR companies are working to meet Meaningful Use (MU) Stage 2 criteria, industry leaders have been collaborating to develop MU Stage 3 requirements.  Last week, the Consumer Partnership for eHealth published an action plan, Leveraging Meaningful Use to Reduce Health Disparities Plan, to leverage MU Stage 3 requirements to reduce health disparities.

According to Healthcare IT News, the proposed action plan:

1. Recommends that EHRs have the ability to stratify patients’ specific conditions by variables such as race, ethnicity, language, gender identity, sexual orientation, socio-economic status and disability status.
2. Calls for greater use of patient data collected and shared through devices such as smartphones.
3. Emphasizes the need to ensure that electronic health information is effectively communicated to patients, so they are better able to utilize its benefits.

The goal is to address health disparities as part of Stage 3 requirements resulting in improved health outcomes and measurement nationwide.  Notable statistics surrounding disparities highlighted in the action plan include:

• 58 million people ages five and older speak a language other than English at home
• 56 million people live with a disability
• Women account for 50.8 percent of the population
• The U.S. Hispanic population reached 50.5 million, increasing 43 percent from the year 2000 and accounting for over half of the total population increase in the U.S.

Checking For Drug Interactions

Follow

Drug-drug and drug-allergy interaction checks are becoming a new standard in electronic health record and e-Prescribing solutions.  Interaction checks are required for meaningful use and are being used by more physicians every day.

Online drug-interaction checking tools are a great at home resource.  They evaluate both prescription and over the counter medication regimens including vitamins and supplements and flag all interactions in real-time.  As online resources continue to pop up, the latest being from CVS, we compiled a list below of valuable drug interaction tools to jumpstart your search:

• CVS
• Drugs.com
• Healthline
• Medscape
• Walgreens

e-Prescribing State By State – Texas

Follow

Featured e-Prescribing State: Texas

Office Based Physicians e-Prescribing in Texas

Interested in another state’s e-Prescribing statistics? Just Contact DoseSpot.

Source: Surescripts State Progress Reports

Meaningful Use: Stage 1 vs. Stage 2

Follow

With Stage 2 right around the corner many EHRs, physicians, dentists, and other ‘eligible professionals’ are seeking guidance. So here it is! Today’s blog post features a Stage 1 vs. Stage 2 Comparison Table for 3 Meaningful Use Core Objectives.

More comparisons are coming…stay tuned!

….Congrats to last week’s DoseSpot #TuesdayTweetup winner @jasmith1437 and runner up @techydoc.

—

Stage 1 Objective: CPOE

Use CPOE for medication orders directly entered by any licensed healthcare professional who can enter orders into the medical record per state, local and professional guidelines

Stage 1 Measure: CPOE

More than 30% of unique patients with at least one medication in their medication list seen by the EP have at least one medication order entered using CPOE

Stage 2 Objective: CPOE

Use computerized provider order entry (CPOE) for medication, laboratory and radiology orders directly entered by any licensed healthcare professional who can enter orders into the medical record per state, local and professional guidelines

Stage 2 Measure: CPOE

More than 60% of medication, 30% of laboratory, and 30% of radiology orders created by the EP during the EHR reporting period are recorded using CPOE

—

Stage 1 Objective: e-Prescribing

Generate and transmit permissible prescriptions electronically (eRx)

Stage 1 Measure: e-Prescribing

More than 30% of unique patients with at least one medication in their medication list seen by the EP have at least one medication order entered using CPOE

Stage 2 Objective: e-Prescribing

Generate and transmit permissible prescriptions electronically (eRx)

Stage 2 Measure: e-Prescribing

More than 50% of all permissible prescriptions written by the EP are compared to at least one drug formulary and transmitted electronically using Certified EHR Technology

—

Stage 1 Objective: Record Demographics

Record demographics: Preferred language, Gender, Race, Ethnicity, Date of birth

Stage 1 Measure: Record Demographics

More than 50% of all unique patients seen by the EP have demographics recorded as structured data

Stage 2 Objective: Record Demographics

Record demographics: Preferred language, Gender, Race, Ethnicity, Date of birth

Stage 2 Measure: Record Demographics

More than 80% of all unique patients seen by the EP have demographics recorded as structured data

Source: http://go.cms.gov/12r3Gsc